Transporter-Mediated Effects of Diclofenamic Acid and Its Ascorbyl Pro-drug in the In Vivo Neurotropic Activity of Ascorbyl Nipecotic Acid Conjugate

Alessandro Dalpiaz, Barbara Pavan, Martina Scaglianti, Federica Vitali, Fabrizio Bortolotti, Carla Biondi, Angelo Scatturin, Sergio Tanganelli, Luca Ferraro, Puttur D Prasad, Stefano Manfredini

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Continuing our studies on SVCT2 ascorbic acid (AA) transporter-mediated drug delivery of neurotropic agents, we have now investigated the in vitro intracellular uptake of Diclofenac (Diclo) and its conjugate (AA-Diclo), both characterized by high affinity for the SVCT2 transporter. We have also investigated the in vivo uptake mechanism of AA-conjugate of Nipecotic acid (AA-Nipec) and the implication of the transporter-mediated effects of Diclo and AA-Diclo. Diclo resulted as a noncompetitive inhibitor of AA transport, but also showed a sodium-dependent and ascorbate-independent uptake, thus implying the possible involvement of specific transporters in the delivery to the brain of Diclo. This result opens a perspective in the discovery of new strategies in the targeting of this drug to the brain. Inhibitory effects of Diclo and AA-Diclo on the SVCT2 transporter were used to study anticonvulsant effects of AA-Nipec, confirming our hypothesis of an SVCT2-mediated transport in its neurotropic activity. AA-Diclo stability has been also investigated: it is hydrolyzed following a first-order kinetics in buffer, plasma (t1/2 at about 10 h) and whole blood (t1/2 at about 3 h), suggesting AA-Diclo as a potential candidate to enhance the short half-life of Diclo in vivo.

Original languageEnglish (US)
Pages (from-to)78-85
Number of pages8
JournalJournal of Pharmaceutical Sciences
Volume93
Issue number1
DOIs
StatePublished - Jan 1 2004

Fingerprint

Diclofenac
Prodrugs
Ascorbic Acid
Acids
nipecotic acid
Brain
Drug Delivery Systems
Anticonvulsants
Half-Life
Buffers

Keywords

  • Active transport
  • Ascorbic acid
  • CNS
  • Diclofenamic acid
  • Nipecotic acid
  • Prodrugs
  • SVCT2
  • Stability
  • Transporters

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Transporter-Mediated Effects of Diclofenamic Acid and Its Ascorbyl Pro-drug in the In Vivo Neurotropic Activity of Ascorbyl Nipecotic Acid Conjugate. / Dalpiaz, Alessandro; Pavan, Barbara; Scaglianti, Martina; Vitali, Federica; Bortolotti, Fabrizio; Biondi, Carla; Scatturin, Angelo; Tanganelli, Sergio; Ferraro, Luca; Prasad, Puttur D; Manfredini, Stefano.

In: Journal of Pharmaceutical Sciences, Vol. 93, No. 1, 01.01.2004, p. 78-85.

Research output: Contribution to journalArticle

Dalpiaz, A, Pavan, B, Scaglianti, M, Vitali, F, Bortolotti, F, Biondi, C, Scatturin, A, Tanganelli, S, Ferraro, L, Prasad, PD & Manfredini, S 2004, 'Transporter-Mediated Effects of Diclofenamic Acid and Its Ascorbyl Pro-drug in the In Vivo Neurotropic Activity of Ascorbyl Nipecotic Acid Conjugate', Journal of Pharmaceutical Sciences, vol. 93, no. 1, pp. 78-85. https://doi.org/10.1002/jps.10532
Dalpiaz, Alessandro ; Pavan, Barbara ; Scaglianti, Martina ; Vitali, Federica ; Bortolotti, Fabrizio ; Biondi, Carla ; Scatturin, Angelo ; Tanganelli, Sergio ; Ferraro, Luca ; Prasad, Puttur D ; Manfredini, Stefano. / Transporter-Mediated Effects of Diclofenamic Acid and Its Ascorbyl Pro-drug in the In Vivo Neurotropic Activity of Ascorbyl Nipecotic Acid Conjugate. In: Journal of Pharmaceutical Sciences. 2004 ; Vol. 93, No. 1. pp. 78-85.
@article{38d5fc664b9a4ccf882092d47c55e3f8,
title = "Transporter-Mediated Effects of Diclofenamic Acid and Its Ascorbyl Pro-drug in the In Vivo Neurotropic Activity of Ascorbyl Nipecotic Acid Conjugate",
abstract = "Continuing our studies on SVCT2 ascorbic acid (AA) transporter-mediated drug delivery of neurotropic agents, we have now investigated the in vitro intracellular uptake of Diclofenac (Diclo) and its conjugate (AA-Diclo), both characterized by high affinity for the SVCT2 transporter. We have also investigated the in vivo uptake mechanism of AA-conjugate of Nipecotic acid (AA-Nipec) and the implication of the transporter-mediated effects of Diclo and AA-Diclo. Diclo resulted as a noncompetitive inhibitor of AA transport, but also showed a sodium-dependent and ascorbate-independent uptake, thus implying the possible involvement of specific transporters in the delivery to the brain of Diclo. This result opens a perspective in the discovery of new strategies in the targeting of this drug to the brain. Inhibitory effects of Diclo and AA-Diclo on the SVCT2 transporter were used to study anticonvulsant effects of AA-Nipec, confirming our hypothesis of an SVCT2-mediated transport in its neurotropic activity. AA-Diclo stability has been also investigated: it is hydrolyzed following a first-order kinetics in buffer, plasma (t1/2 at about 10 h) and whole blood (t1/2 at about 3 h), suggesting AA-Diclo as a potential candidate to enhance the short half-life of Diclo in vivo.",
keywords = "Active transport, Ascorbic acid, CNS, Diclofenamic acid, Nipecotic acid, Prodrugs, SVCT2, Stability, Transporters",
author = "Alessandro Dalpiaz and Barbara Pavan and Martina Scaglianti and Federica Vitali and Fabrizio Bortolotti and Carla Biondi and Angelo Scatturin and Sergio Tanganelli and Luca Ferraro and Prasad, {Puttur D} and Stefano Manfredini",
year = "2004",
month = "1",
day = "1",
doi = "10.1002/jps.10532",
language = "English (US)",
volume = "93",
pages = "78--85",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Transporter-Mediated Effects of Diclofenamic Acid and Its Ascorbyl Pro-drug in the In Vivo Neurotropic Activity of Ascorbyl Nipecotic Acid Conjugate

AU - Dalpiaz, Alessandro

AU - Pavan, Barbara

AU - Scaglianti, Martina

AU - Vitali, Federica

AU - Bortolotti, Fabrizio

AU - Biondi, Carla

AU - Scatturin, Angelo

AU - Tanganelli, Sergio

AU - Ferraro, Luca

AU - Prasad, Puttur D

AU - Manfredini, Stefano

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Continuing our studies on SVCT2 ascorbic acid (AA) transporter-mediated drug delivery of neurotropic agents, we have now investigated the in vitro intracellular uptake of Diclofenac (Diclo) and its conjugate (AA-Diclo), both characterized by high affinity for the SVCT2 transporter. We have also investigated the in vivo uptake mechanism of AA-conjugate of Nipecotic acid (AA-Nipec) and the implication of the transporter-mediated effects of Diclo and AA-Diclo. Diclo resulted as a noncompetitive inhibitor of AA transport, but also showed a sodium-dependent and ascorbate-independent uptake, thus implying the possible involvement of specific transporters in the delivery to the brain of Diclo. This result opens a perspective in the discovery of new strategies in the targeting of this drug to the brain. Inhibitory effects of Diclo and AA-Diclo on the SVCT2 transporter were used to study anticonvulsant effects of AA-Nipec, confirming our hypothesis of an SVCT2-mediated transport in its neurotropic activity. AA-Diclo stability has been also investigated: it is hydrolyzed following a first-order kinetics in buffer, plasma (t1/2 at about 10 h) and whole blood (t1/2 at about 3 h), suggesting AA-Diclo as a potential candidate to enhance the short half-life of Diclo in vivo.

AB - Continuing our studies on SVCT2 ascorbic acid (AA) transporter-mediated drug delivery of neurotropic agents, we have now investigated the in vitro intracellular uptake of Diclofenac (Diclo) and its conjugate (AA-Diclo), both characterized by high affinity for the SVCT2 transporter. We have also investigated the in vivo uptake mechanism of AA-conjugate of Nipecotic acid (AA-Nipec) and the implication of the transporter-mediated effects of Diclo and AA-Diclo. Diclo resulted as a noncompetitive inhibitor of AA transport, but also showed a sodium-dependent and ascorbate-independent uptake, thus implying the possible involvement of specific transporters in the delivery to the brain of Diclo. This result opens a perspective in the discovery of new strategies in the targeting of this drug to the brain. Inhibitory effects of Diclo and AA-Diclo on the SVCT2 transporter were used to study anticonvulsant effects of AA-Nipec, confirming our hypothesis of an SVCT2-mediated transport in its neurotropic activity. AA-Diclo stability has been also investigated: it is hydrolyzed following a first-order kinetics in buffer, plasma (t1/2 at about 10 h) and whole blood (t1/2 at about 3 h), suggesting AA-Diclo as a potential candidate to enhance the short half-life of Diclo in vivo.

KW - Active transport

KW - Ascorbic acid

KW - CNS

KW - Diclofenamic acid

KW - Nipecotic acid

KW - Prodrugs

KW - SVCT2

KW - Stability

KW - Transporters

UR - http://www.scopus.com/inward/record.url?scp=9144238106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9144238106&partnerID=8YFLogxK

U2 - 10.1002/jps.10532

DO - 10.1002/jps.10532

M3 - Article

VL - 93

SP - 78

EP - 85

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 1

ER -